Democratizing science by creating evidence-based solutions that are simple, clear, and actionable.

Translating multi-omics data into actionable insights to patients and providers.

Grew a team to 8 scientists responsible for generating insights from complex omics and patient-generated health data (PGHD) and identifying real world applications for scientific discoveries across multiple uses – diagnostics, targets, predicted biomarkers, digital health applications, n-of-1.

Responsible for the entire life cycle of digital health programs (design, planning, implementation, and reporting to partners) using our mobile applications to promote better disease management and outcomes in transplantation, oncology, diabetes, and cardiac failure therapeutic areas.

GBI is a Big Data analytic company providing game-changing information and tools for Pharmaceutical, Healthcare, Biotechnology, and Consumer sectors in China and Brazil and expanding to Latin America and US. Responsible for enterprise products.

GBI is a Big Data analytic company providing game-changing information and tools for Pharmaceutical, Healthcare, Biotechnology, and Consumer sectors in China and Brazil. Responsible for LATAM products.

Scientific support for sales and internal projects, client trainings, and customer relationship.

Selventa is a systems biology company, which has developed a platform to discover and define molecular mechanisms for diseases and drugs, and identify biomarkers. Led teams of 3-4 Ph.D level scientists and primary scientific contact for client engagements.

Applied Genstruct proprietary platform to model biological systems for drug discovery and development.

Developed basic science research with Dr. PereiraPerrin, a leading scientists in the Trypanosoma cruzi field. Research focused on the Trypanasoma cruzi-nervous system interaction.